VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DNTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DNTHDianthus Therapeutics, Inc.
$88.21$3.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDNTHQuarterly Cash Flow

Dianthus Therapeutics, Inc. (DNTH) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Dianthus Therapeutics, Inc. (DNTH) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

DNTH Cash Flow Statement

Quarterly statement

DNTH Cash Flow Statement

Dianthus Therapeutics, Inc. (DNTH) cash flow statement — 10-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-48.98M-28.86M-46.98M-30.55M-23.89M-27.63M-27.44M-21.27M-14.53M-14.94M-11.85M1.5M-4.73M-10.28M-8.85M16.38M-16.85M-19.74M-15.69M-14.07M
Operating CF Margin %-6436.4%-6232.4%-16543.31%-7715.91%-12379.27%-2375.75%-2069.68%-979.14%-779.82%-1709.5%-2593.87%162.01%-488.24%-2160.5%-753.28%1395.99%----
Operating CF Growth %-105.01%-4.44%-71.2%-43.67%-64.45%-84.93%-131.52%-1520.64%-207.08%-45.28%-33.93%-90.86%71.93%47.91%43.59%216.41%-29.64%-17.69%-14.25%2.5%
Net Income-50.22M-40.83M-64.43M-36.77M-31.63M-29.51M-28.44M-25.17M-17.61M-13.75M-10.56M-14.76M-11.14M-7.09M-10.12M-7.78M-17.27M-22.95M-19.29M-17.43M
Depreciation & Amortization-7K76K97K99K99K133K78K116K111K107K103K19K84K81K49K1.21M1.2M1.21M535K532K
Stock-Based Compensation11.9M10.6M5.98M5.79M5.71M5.32M3.92M3.84M3.1M2.04M726K1.18M462K533K513K00000
Deferred Taxes00000000000000000000
Other Non-Cash Items-5.64M-916K-1.11M-2.54M-1.12M-1.9M-2.58M-2.65M-422K-518K-527K4.68M-208K-358K-402K22.95M1.96M2.02M2.26M4M
Working Capital Changes-5.01M2.22M12.48M2.85M3.05M-1.66M-422K2.6M289K-2.82M-1.59M10.38M6.07M-3.45M1.1M-1K-2.74M-21K806K-1.17M
Change in Receivables1.12M-1.18M4.95M-4.96M961K-193K1.88M-1.01M-799K-398K273K03.69M1.17M-1.15M00000
Change in Inventory00000000000000000000
Change in Payables-7M7M6.68M3M3.09M-1.5M2.28M5.65M3.25M-2.99M1.6M484K3.01M-4.73M2.03M1.24M-2.39M1.4M1.15M122K
Cash from Investing-478.52M-133.97M37.2M-201.28M26.45M14.79M-23.11M-259.36M1.17M-5.51M-8.24M-16.88M21.86M18.13M-12.66M-6.88M-129K-40.14M-10.32M16.37M
Capital Expenditures-181K-10K-138K-5K-46K-24K-31K-25K-17K-32K-10K145K-21K-14K-29K46K-129K-27K-15K-1.13M
CapEx % of Revenue23.78%2.16%48.59%1.26%23.83%2.06%2.34%1.15%0.91%3.66%2.19%15.69%2.17%2.94%2.47%3.92%----
Acquisitions00000000000-5.38M00000000
Investments--------------------
Other Investing00000000000000000000
Cash from Financing10.38M739.41M4.88M274.51M568K161K39.68M296K-2.2M217.85M-4.87M154.08M00096.63M49K0124K203K
Debt Issued (Net)0000000000015.64M00000000
Equity Issued (Net)-674.28M739.41M-275.24M274.51M568K161K39.2M296K215.38M230M072M00096.63M49K0124K203K
Dividends Paid00000000000000000000
Share Repurchases00317K00000000000000000
Other Financing684.66M0280.13M000476K0-217.58M-12.15M-4.87M66.44M00000000
Net Change in Cash-517.12M576.58M-4.9M42.68M3.12M-12.68M-10.88M-280.5M-15.55M197.4M-24.96M94.65M17.13M7.85M-21.52M4.2M-16.93M-59.88M-25.89M2.5M
Free Cash Flow-49.16M-28.87M-47.12M-30.56M-23.94M-27.65M-27.48M-21.29M-14.54M-14.97M-11.86M1.64M-4.75M-10.3M-8.88M16.42M-16.98M-19.77M-15.71M-15.2M
FCF Margin %-6460.18%-6234.56%-16591.9%-7717.17%-12403.11%-2377.82%-2072.02%-980.29%-780.73%-1713.16%-2596.06%177.71%-490.4%-2163.45%-755.74%1399.91%----
FCF Growth %-105.37%-4.38%-71.5%-43.53%-64.58%-84.69%-131.58%-1396.71%-206.08%-45.4%-33.6%-90%72.02%47.91%43.46%208.05%-29.52%-17.8%-12.61%-5.19%
FCF per Share-0.88-0.60-1.25-0.81-0.67-0.77-0.78-0.62-0.42-0.58-2.620.42-1.25-2.72-2.344.43-4.62-5.38-4.27-4.15
FCF Conversion (FCF/Net Income)0.98x0.71x-0.48x0.83x0.76x0.94x0.96x0.84x0.83x1.09x1.12x-0.10x0.42x1.45x0.87x-2.10x0.98x0.86x0.81x0.81x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000